These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6132998)

  • 1. Cardioselectivity of beta-adrenoceptor blocking agents. 2. Role of the amino group substituent.
    Rzeszotarski WJ; Gibson RE; Simms DA; Jagoda EM; Vaughan JN; Eckelman WC
    J Med Chem; 1983 May; 26(5):644-8. PubMed ID: 6132998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioselectivity of beta-adrenoceptor blocking agents 1. 1-[(4-Hydroxyphenethyl)amino]-3-(aryloxy)propan-2-ols.
    Rzeszotarski WJ; Gibson RE; Eckelman WC; Reba RC
    J Med Chem; 1979 Jun; 22(6):735-7. PubMed ID: 37339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioselectivity as a function of molecular structure in beta-adrenoceptor blocking agents of the 1-(para-substituted aryloxy)-3-(isopropylamino)propan-2-ol type.
    Erez M; Shtacher G; Weinstock M
    J Med Chem; 1978 Sep; 21(9):982-4. PubMed ID: 31488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Adrenergic blocking agents. 23. 1-[Substituted-amido)phenoxy]-3-[[(substituted-amido)alkyl]amino] propan-2-ols.
    Large MS; Smith LH
    J Med Chem; 1983 Mar; 26(3):352-7. PubMed ID: 6131134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodinated derivatives of beta adrenoceptor blockers for myocardial imaging.
    Jiang VW; Gibson RE; Rzeszotarski WJ; Eckelman WC; Reba RC
    J Nucl Med; 1978 Aug; 19(8):918-24. PubMed ID: 28388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenoceptor blocking agents. 1. Cardioselective 1-aryloxy-3-(aryloxyalkylamino)propan-2-ols.
    Augstein J; Cox DA; Ham AL; Leeming PR; Snarey M
    J Med Chem; 1973 Nov; 16(11):1245-51. PubMed ID: 4147835
    [No Abstract]   [Full Text] [Related]  

  • 7. beta-Adrenergic blocking agents. 18. 1-(Aryloxy)-3-(arylthioalkylamino)propan-2-ols and 1-substituted alkylthioamino-3-(aryloxy)propan-2-ols.
    Tucker H; Coope JF
    J Med Chem; 1978 Aug; 21(8):769-73. PubMed ID: 29123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-adrenergic blocking agents. 24. Heterocyclic substituted 1-(aryloxy)-3-[[(amido)alkyl]amino]propan-2-ols.
    Large MS; Smith LH
    J Med Chem; 1982 Dec; 25(12):1417-22. PubMed ID: 6130155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and biodistribution of a 125I-labeled beta-adrenoceptor antagonist bearing a cardioselectivity-enhancing N-substituent.
    Hanson RN; Blumberg JB; Poddubiuk ZM; Davis MA; Holman BL
    Int J Appl Radiat Isot; 1981 Jun; 32(6):429-33. PubMed ID: 6114044
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of beta adrenoceptor antagonist affinity and cardioselectivity by radioligand-receptor assay.
    Gibson RE; Rzeszotarski WJ; Komai T; Reba RC; Eckelman WC
    J Pharmacol Exp Ther; 1979 Apr; 209(1):153-61. PubMed ID: 34714
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta-adrenergic blocking agents. 20. (3-Hydroxyprop-1-enyl)-substituted 1-(aryloxy)-3-(alkylamino)propan-2-ols.
    Tucker H
    J Med Chem; 1980 Oct; 23(10):1122-6. PubMed ID: 6106716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Adrenergic blocking agents. 17. 1-Phenoxy-3-phenoxyalkylamino-2-propanols and 1-alkoxyalkylamino-3-phenoxy-2-propanols.
    Smith LH; Tucker H
    J Med Chem; 1977 Dec; 20(12):1653-6. PubMed ID: 22750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.
    Hoefle ML; Hastings SG; Meyer RF; Corey RM; Holmes A; Stratton CD
    J Med Chem; 1975 Feb; 18(2):148-52. PubMed ID: 235644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis.
    Van Inwegen RG; Khandwala A; Weinryb I; Pruss TP; Neiss E; Sutherland CA
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):40-55. PubMed ID: 6151380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and binding to beta-adrenergic receptors of p-aminobenzyl analogues of practolol and atenolol.
    Jones GS; Bylund DB; Hanson RN
    J Pharm Sci; 1992 Apr; 81(4):397-8. PubMed ID: 1354250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies regarding the structure activity relationships of beta-adrenoceptor antagonists.
    Bagwell EE; Williams EM
    Br J Pharmacol; 1973 Aug; 48(4):686-92. PubMed ID: 4150921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships as a response to the pharmacological differences in beta-receptor ligands.
    Labrid C; Rocher I; Guery O
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):245S-251S. PubMed ID: 2573372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of pharmacological and binding assays for ten beta-adrenoceptor blocking agents and two beta-adrenoceptor agonists.
    Bieth N; Rouot B; Schwartz J; Velly J
    Br J Pharmacol; 1980 Mar; 68(3):563-9. PubMed ID: 6132636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo receptor binding of iodinated beta-adrenoceptor blockers.
    Eckelman WC; Gibson RE; Vieras F; Rzeszotarski WJ; Francis B; Reba RC
    J Nucl Med; 1980 May; 21(5):436-42. PubMed ID: 6103024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic aspects of cardioselectivity in a beta-blocking drug.
    McDevitt DG
    Am J Cardiol; 1987 May; 59(13):10F-12F. PubMed ID: 2883870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.